1. Neutrophil extracellular traps in cancer progression
- Author
-
Lorenzo E. Ferri, Jonathan Spicer, Sara Najmeh, and Jonathan Cools-Lartigue
- Subjects
Cathepsin G ,Neutrophils ,Antimicrobial peptides ,Metastatis ,Inflammation ,Review ,Biology ,medicine.disease_cause ,Neutrophil extracellular traps ,Extracellular Traps ,Metastasis ,Cellular and Molecular Neuroscience ,Cell Movement ,Cell Line, Tumor ,Neoplasms ,Cell Adhesion ,medicine ,Animals ,Humans ,Neoplasm Invasiveness ,Neoplasm Metastasis ,Cell adhesion ,Molecular Biology ,Cancer ,Pharmacology ,Neutrophil ,DNA ,Cell Biology ,medicine.disease ,Chromatin ,Matrix Metalloproteinase 9 ,Tumor progression ,Immunology ,Disease Progression ,Cancer research ,Molecular Medicine ,medicine.symptom ,Leukocyte Elastase ,Carcinogenesis ,Antimicrobial Cationic Peptides - Abstract
Neutrophils are being increasingly recognized as an important element in tumor progression. They have been shown to exert important effects at nearly every stage of tumor progression with a number of studies demonstrating that their presence is critical to tumor development. Novel aspects of neutrophil biology have recently been elucidated and its contribution to tumorigenesis is only beginning to be appreciated. Neutrophil extracellular traps (NETs) are neutrophil-derived structures composed of DNA decorated with antimicrobial peptides. They have been shown to trap and kill microorganisms, playing a critical role in host defense. However, their contribution to tumor development and metastasis has recently been demonstrated in a number of studies highlighting NETs as a potentially important therapeutic target. Here, studies implicating NETs as facilitators of tumor progression and metastasis are reviewed. In addition, potential mechanisms by which NETs may exert these effects are explored. Finally, the ability to target NETs therapeutically in human neoplastic disease is highlighted.
- Published
- 2014
- Full Text
- View/download PDF